Health Catalyst, Inc. — Director's Dealing 2021

Jan 20, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Health Catalyst, Inc. (HCAT)
CIK: 0001636422
Period of Report: 2021-01-14

Reporting Person: Alger Jason (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-14	Common Stock	M	780.00	$10.78	Acquired	3905.00	Direct
2021-01-14	Common Stock	M	2340.00	$10.72	Acquired	6245.00	Direct
2021-01-14	Common Stock	M	832.00	$10.60	Acquired	7077.00	Direct
2021-01-14	Common Stock	M	2349.00	$10.80	Acquired	9426.00	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-14	Stock Option (Right to Buy)	$10.80	M	2349.00	Disposed	2028-09-27	Common Stock (2349.00)	Direct
2021-01-14	Stock Option (Right to Buy)	$10.78	M	780.00	Disposed	2028-05-03	Common Stock (780.00)	Direct
2021-01-14	Stock Option (Right to Buy)	$10.72	M	2340.00	Disposed	2027-10-26	Common Stock (2340.00)	Direct
2021-01-14	Stock Option (Right to Buy)	$10.60	M	832.00	Disposed	2026-10-14	Common Stock (832.00)	Direct

Footnotes

F1: 25% of the 11,805 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022.

F2: 25% of the 4,150 shares underlying the options vested in an annual installment on May 3, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on May 3, 2022.

F3: 25% of the 12,500 shares underlying the options vested in an annual installment on October 26, 2018 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on October 26, 2021.

F4: 25% of the 5,000 shares underlying the options vested in an annual installment on October 14, 2017 and the remaining balance vested in equal monthly installments until the option vested in full on October 14, 2020.